Wells Fargo’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $55.5K | Buy |
15,900
+1,000
| +7% | +$3.6K | ﹤0.01% | 5423 |
|
|
2025
Q4 | $51K | Buy |
14,900
+1,900
| +15% | +$8.48K | ﹤0.01% | 5575 |
|
|
2025
Q3 | $65.4K | Buy |
13,000
+1,200
| +10% | +$5.29K | ﹤0.01% | 5475 |
|
|
2025
Q2 | $40.5K | Sell |
11,800
-1,330
| -10% | -$3.31K | ﹤0.01% | 5584 |
|
|
2025
Q1 | $29.3K | Hold |
13,130
| – | – | ﹤0.01% | 5580 |
|
|
2024
Q4 | $38.5K | Buy |
13,130
+250
| +2% | +$696 | ﹤0.01% | 5571 |
|
|
2024
Q3 | $33.5K | Sell |
12,880
-2,800
| -18% | -$7.76K | ﹤0.01% | 5494 |
|
|
2024
Q2 | $46.4K | Sell |
15,680
-12,436
| -44% | -$47.1K | ﹤0.01% | 5321 |
|
|
2024
Q1 | $127K | Sell |
28,116
-2,200
| -7% | -$11.2K | ﹤0.01% | 4752 |
|
|
2023
Q4 | $173K | Sell |
30,316
-6,525
| -18% | -$30.2K | ﹤0.01% | 4550 |
|
|
2023
Q3 | $169K | Sell |
36,841
-75,139
| -67% | -$457K | ﹤0.01% | 4465 |
|
|
2023
Q2 | $723K | Sell |
111,980
-31,156
| -22% | -$213K | ﹤0.01% | 3679 |
|
|
2023
Q1 | $1.08M | Buy |
143,136
+58,806
| +70% | +$534K | ﹤0.01% | 3321 |
|
|
2022
Q4 | $854K | Buy |
84,330
+7,441
| +10% | +$86K | ﹤0.01% | 3338 |
|
|
2022
Q3 | $760K | Buy |
76,889
+3,798
| +5% | +$41.7K | ﹤0.01% | 3413 |
|
|
2022
Q2 | $778K | Buy |
73,091
+10,040
| +16% | +$85K | ﹤0.01% | 3454 |
|
|
2022
Q1 | $615K | Sell |
63,051
-29,132
| -32% | -$276K | ﹤0.01% | 4261 |
|
|
2021
Q4 | $1.32M | Sell |
92,183
-54,208
| -37% | -$823K | ﹤0.01% | 3877 |
|
|
2021
Q3 | $2.93M | Buy |
146,391
+95,669
| +189% | +$1.69M | ﹤0.01% | 3345 |
|
|
2021
Q2 | $1.12M | Sell |
50,722
-24,950
| -33% | -$688K | ﹤0.01% | 4136 |
|
|
2021
Q1 | $2.57M | Buy |
75,672
+75,472
| +37,736% | +$3.01M | ﹤0.01% | 3474 |
|
|
2020
Q4 | $8K | Buy |
+200
| New | +$9.15K | ﹤0.01% | 6056 |
|
Other funds holding ABCL
BBA
TWC
ACH
DCM
